Identification and consequences of galectin-3 expression in pituitary tumors

A. Righi, L. Jin, S. Zhang, G. Stilling, B. W. Scheithauer, K. Kovacs, R. V. Lloyd

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Although the mechanisms regulating pituitary tumor development and progression are still unclear, new information on the molecular mechanisms involved in the pathogenesis of human pituitary tumors have accumulated. Recent evidence suggests that galectin-3 plays an important role in pituitary tumorigenesis and in tumor progression. Galectin-3 is expressed in a variety of tumors and the intensity of expression and localization depend on tumor progression, invasiveness and metastatic potential. Galectin-3 expression has been used as a potential diagnostic and/or prognostic marker in a variety of neoplasms. This review summarizes existing information regarding the structural and functional properties of galectin-3 protein as well as the LGALS3 gene in pituitary tumorigenesis. Given its role in pituitary tumor cell proliferation and in apoptosis, galectin-3 may be a target for the treatment of aggressive pituitary tumors.

Original languageEnglish
Pages (from-to)8-14
Number of pages7
JournalMolecular and Cellular Endocrinology
Volume326
Issue number1-2
DOIs
Publication statusPublished - Sep 2010

Fingerprint

Galectin 3
Pituitary Neoplasms
Tumors
Neoplasms
Carcinogenesis
Cell proliferation
Cell Proliferation
Apoptosis
Genes
Proteins

Keywords

  • ACTH adenoma
  • Folliculo-stellate cells
  • Galectin-3
  • Pituitary
  • PRL adenoma
  • Tumor

ASJC Scopus subject areas

  • Endocrinology
  • Molecular Biology
  • Biochemistry

Cite this

Righi, A., Jin, L., Zhang, S., Stilling, G., Scheithauer, B. W., Kovacs, K., & Lloyd, R. V. (2010). Identification and consequences of galectin-3 expression in pituitary tumors. Molecular and Cellular Endocrinology, 326(1-2), 8-14. https://doi.org/10.1016/j.mce.2010.04.026

Identification and consequences of galectin-3 expression in pituitary tumors. / Righi, A.; Jin, L.; Zhang, S.; Stilling, G.; Scheithauer, B. W.; Kovacs, K.; Lloyd, R. V.

In: Molecular and Cellular Endocrinology, Vol. 326, No. 1-2, 09.2010, p. 8-14.

Research output: Contribution to journalArticle

Righi, A, Jin, L, Zhang, S, Stilling, G, Scheithauer, BW, Kovacs, K & Lloyd, RV 2010, 'Identification and consequences of galectin-3 expression in pituitary tumors', Molecular and Cellular Endocrinology, vol. 326, no. 1-2, pp. 8-14. https://doi.org/10.1016/j.mce.2010.04.026
Righi, A. ; Jin, L. ; Zhang, S. ; Stilling, G. ; Scheithauer, B. W. ; Kovacs, K. ; Lloyd, R. V. / Identification and consequences of galectin-3 expression in pituitary tumors. In: Molecular and Cellular Endocrinology. 2010 ; Vol. 326, No. 1-2. pp. 8-14.
@article{2b7c01373dd74372813744f038526c82,
title = "Identification and consequences of galectin-3 expression in pituitary tumors",
abstract = "Although the mechanisms regulating pituitary tumor development and progression are still unclear, new information on the molecular mechanisms involved in the pathogenesis of human pituitary tumors have accumulated. Recent evidence suggests that galectin-3 plays an important role in pituitary tumorigenesis and in tumor progression. Galectin-3 is expressed in a variety of tumors and the intensity of expression and localization depend on tumor progression, invasiveness and metastatic potential. Galectin-3 expression has been used as a potential diagnostic and/or prognostic marker in a variety of neoplasms. This review summarizes existing information regarding the structural and functional properties of galectin-3 protein as well as the LGALS3 gene in pituitary tumorigenesis. Given its role in pituitary tumor cell proliferation and in apoptosis, galectin-3 may be a target for the treatment of aggressive pituitary tumors.",
keywords = "ACTH adenoma, Folliculo-stellate cells, Galectin-3, Pituitary, PRL adenoma, Tumor",
author = "A. Righi and L. Jin and S. Zhang and G. Stilling and Scheithauer, {B. W.} and K. Kovacs and Lloyd, {R. V.}",
year = "2010",
month = "9",
doi = "10.1016/j.mce.2010.04.026",
language = "English",
volume = "326",
pages = "8--14",
journal = "Molecular and Cellular Endocrinology",
issn = "0303-7207",
publisher = "Elsevier Ireland Ltd",
number = "1-2",

}

TY - JOUR

T1 - Identification and consequences of galectin-3 expression in pituitary tumors

AU - Righi, A.

AU - Jin, L.

AU - Zhang, S.

AU - Stilling, G.

AU - Scheithauer, B. W.

AU - Kovacs, K.

AU - Lloyd, R. V.

PY - 2010/9

Y1 - 2010/9

N2 - Although the mechanisms regulating pituitary tumor development and progression are still unclear, new information on the molecular mechanisms involved in the pathogenesis of human pituitary tumors have accumulated. Recent evidence suggests that galectin-3 plays an important role in pituitary tumorigenesis and in tumor progression. Galectin-3 is expressed in a variety of tumors and the intensity of expression and localization depend on tumor progression, invasiveness and metastatic potential. Galectin-3 expression has been used as a potential diagnostic and/or prognostic marker in a variety of neoplasms. This review summarizes existing information regarding the structural and functional properties of galectin-3 protein as well as the LGALS3 gene in pituitary tumorigenesis. Given its role in pituitary tumor cell proliferation and in apoptosis, galectin-3 may be a target for the treatment of aggressive pituitary tumors.

AB - Although the mechanisms regulating pituitary tumor development and progression are still unclear, new information on the molecular mechanisms involved in the pathogenesis of human pituitary tumors have accumulated. Recent evidence suggests that galectin-3 plays an important role in pituitary tumorigenesis and in tumor progression. Galectin-3 is expressed in a variety of tumors and the intensity of expression and localization depend on tumor progression, invasiveness and metastatic potential. Galectin-3 expression has been used as a potential diagnostic and/or prognostic marker in a variety of neoplasms. This review summarizes existing information regarding the structural and functional properties of galectin-3 protein as well as the LGALS3 gene in pituitary tumorigenesis. Given its role in pituitary tumor cell proliferation and in apoptosis, galectin-3 may be a target for the treatment of aggressive pituitary tumors.

KW - ACTH adenoma

KW - Folliculo-stellate cells

KW - Galectin-3

KW - Pituitary

KW - PRL adenoma

KW - Tumor

UR - http://www.scopus.com/inward/record.url?scp=77955427083&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77955427083&partnerID=8YFLogxK

U2 - 10.1016/j.mce.2010.04.026

DO - 10.1016/j.mce.2010.04.026

M3 - Article

VL - 326

SP - 8

EP - 14

JO - Molecular and Cellular Endocrinology

JF - Molecular and Cellular Endocrinology

SN - 0303-7207

IS - 1-2

ER -